Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for Functional Abdominal Pain in Children
NCT01675050Phase 2Terminated
- Sponsor
- University of Michigan
- Start
- Aug 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyproheptadine in functional abdominal pain (FAP), sponsored by University of Michigan. Started Aug 2012; status: terminated.
02
Drugs
cyproheptadine
03
Conditions
functional abdominal pain (FAP)
Beyond the preview
Go deeper on NCT01675050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675050.